SOPHARMA AD: Notification for Buy-back of treasury shares

2023-12-21 16:16

publikacja
2023-12-21 16:16

Spis treści:

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
SFA_buyback_20122023_espi.pdf (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		250	/	2023
Date of issue:	2023-12-21
Short name of the issuer
SOPHARMA AD
Subject
Notification for Buy-back of treasury shares
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
“Sopharma” AD (the Company) notifies that on the basis of Art. 187b of the Commercial Law and Art. 111 para. 5 and para. 6 of LPOS and in connection with a decision of the General Meeting of the company held on 4 August 2023 and a decision of the Board of Directors of December 21, 2023, “Sopharma” AD notifies that the company intends to buy back treasury shares within the limit according to Art. 111, para. 5 of the Law on Public Offering of Securities, as follows:
Annexes
File			Description
SFA_buyback_20122023_espi.pdfSFA_buyback_20122023_espi.pdf			Notification for Buy-back of treasury shares

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2023-12-21	Ognian Donev	Executive director

Ważne linki